You cannot register for this webinar

This webinar has ended. Thank you for your interest.

Topic
Streamlined mRNA Vaccine Characterization with the VaxArray Platform
Date & Time

Selected Sessions:

Dec 4, 2024 02:00 PM

Description
In this webinar, Dr. Lacey will showcase the utility of the VaxArray platform throughout mRNA vaccine development. He will specifically focus on off-the-shelf VaxArray assays including the recently released 5’ CapQ Assay for assessing mRNA integrity as well as the OmniFlu HA/NA Assay for multiplexed analysis of expressed influenza antigens. Additionally, he will highlight the essential role that Sino Biological plays in ensuring that InDevR has the most up-to-date and effective reagents for testing and updating VaxArray assays. The emergence of mRNA vaccines has necessitated the development of a new suite of analytical techniques for characterizing mRNA critical quality attributes. Conventional techniques such as HPLC, capillary electrophoresis, ELISA, and flow cytometry can offer analytical solutions for mRNA-based vaccine development, though these approaches often pose challenges in terms of complexity, time consumption, and resource requirements. InDevR's VaxArray® platform addresses many of these limitations providing solutions for simplifying and streamlining mRNA vaccine analytics. The VaxArray platform is a multiplexed, microarray-based technology that delivers a one-stop solution for characterizing mRNA constructs, measuring in vitro protein expression post-transfection of mRNA vaccine constructs, and assessing immunological responses to mRNA vaccines. With the VaxArray platform, InDevR offers off-the-shelf, multiplexed assay kits alongside user-friendly instrumentation and data analysis tools that facilitate rapid sample processing. Additionally, InDevR’s Expert Services offers custom assay development for a wide variety of customer-specific applications, ensuring the same high standards of quality and manufacturing as off-the-shelf counterparts.